钴胺依赖的自由基SAM酶激活自由基氟甲基化。

IF 3.8 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
ACS Bio & Med Chem Au Pub Date : 2025-05-06 eCollection Date: 2025-06-18 DOI:10.1021/acsbiomedchemau.5c00062
Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker
{"title":"钴胺依赖的自由基SAM酶激活自由基氟甲基化。","authors":"Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker","doi":"10.1021/acsbiomedchemau.5c00062","DOIUrl":null,"url":null,"abstract":"<p><p>Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of <i>S</i>-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar S<sub>N</sub>2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that <i>S</i>-adenosyl-<i>L</i>-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where S<sub>N</sub>2-based fluoromethylation is precluded.</p>","PeriodicalId":29802,"journal":{"name":"ACS Bio & Med Chem Au","volume":"5 3","pages":"464-474"},"PeriodicalIF":3.8000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183590/pdf/","citationCount":"0","resultStr":"{\"title\":\"Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes.\",\"authors\":\"Syam Sundar Neti, Bo Wang, Jiayuan Cui, David F Iwig, Nicholas J York, Anthony J Blaszczyk, Matthew R Bauerle, Squire J Booker\",\"doi\":\"10.1021/acsbiomedchemau.5c00062\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of <i>S</i>-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar S<sub>N</sub>2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that <i>S</i>-adenosyl-<i>L</i>-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where S<sub>N</sub>2-based fluoromethylation is precluded.</p>\",\"PeriodicalId\":29802,\"journal\":{\"name\":\"ACS Bio & Med Chem Au\",\"volume\":\"5 3\",\"pages\":\"464-474\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-05-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12183590/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Bio & Med Chem Au\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1021/acsbiomedchemau.5c00062\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/18 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Bio & Med Chem Au","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/acsbiomedchemau.5c00062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/18 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

氟在许多药物中是一个重要的原子,因为它可以提高许多分子的功效和代谢稳定性。与二氟甲基化或三氟甲基化战略相比,将单氟甲基化纳入药物的战略受到的关注较少。之前,我们和其他人报道了几种生物相关代谢物的酶促单氟甲基化,其基础是通过极性SN2机制将s -腺苷蛋氨酸(SAM)类似物的氟甲基转移到各种亲核试剂(碳、氧、氮、硫和碳)上。然而,这种策略仅限于含有亲核靶原子的分子。受到自由基SAM超家族中可以甲基化惰性碳原子的酶的启发,我们开发了一种将氟甲基转移到非活性碳原子上的酶的策略。该策略利用卤化物甲基转移酶的能力来生成一种瞬态含氟甲基的SAM类似物。我们的研究表明,s -腺苷基- l-(氟甲基)-蛋氨酸可以被还原裂解为5'-脱氧腺苷基5'-自由基,通过底物氢原子的提取引发自由基依赖的氟甲基化。使用自由基SAM酶在未活化的C-H键上添加氟甲基是一种强大的方法,可用于衍生感兴趣的分子,其中sn2基氟甲基化被排除在外。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Radical Fluoromethylation Enabled by Cobalamin-Dependent Radical SAM Enzymes.

Fluorine is an important atom in many drugs because it can improve the efficacy and metabolic stability of many molecules. Strategies to incorporate monofluoromethyl groups in drugs have been limited and have received less attention than strategies for difluoromethylation or trifluoromethylation. Previously, we and others reported the enzymatic monofluoromethylation of several biologically relevant metabolites based on the transfer of a fluoromethyl group from analogs of S-adenosylmethionine (SAM) to various nucleophiles (carbon, oxygen, nitrogen, sulfur, and carbon) through a polar SN2 mechanism. However, this strategy is limited to molecules containing nucleophilic target atoms. Inspired by a subset of enzymes within the radical SAM superfamily that can methylate inert carbon atoms, we developed an enzymatic strategy to transfer fluoromethyl groups to unactivated carbon atoms. This strategy leverages the ability of halide methyltransferase to generate a transient fluoromethyl-containing SAM analog. Our studies show that S-adenosyl-L-(fluoromethyl)-methionine can undergo reductive cleavage to a 5'-deoxyadenosyl 5'-radical, which initiates radical-dependent fluoromethylation through substrate hydrogen-atom abstraction. Adding fluoromethyl groups to unactivated C-H bonds using radical SAM enzymes is a powerful approach that can be used to derivatize molecules of interest where SN2-based fluoromethylation is precluded.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Bio & Med Chem Au
ACS Bio & Med Chem Au 药物、生物、化学-
CiteScore
4.10
自引率
0.00%
发文量
0
期刊介绍: ACS Bio & Med Chem Au is a broad scope open access journal which publishes short letters comprehensive articles reviews and perspectives in all aspects of biological and medicinal chemistry. Studies providing fundamental insights or describing novel syntheses as well as clinical or other applications-based work are welcomed.This broad scope includes experimental and theoretical studies on the chemical physical mechanistic and/or structural basis of biological or cell function in all domains of life. It encompasses the fields of chemical biology synthetic biology disease biology cell biology agriculture and food natural products research nucleic acid biology neuroscience structural biology and biophysics.The journal publishes studies that pertain to a broad range of medicinal chemistry including compound design and optimization biological evaluation molecular mechanistic understanding of drug delivery and drug delivery systems imaging agents and pharmacology and translational science of both small and large bioactive molecules. Novel computational cheminformatics and structural studies for the identification (or structure-activity relationship analysis) of bioactive molecules ligands and their targets are also welcome. The journal will consider computational studies applying established computational methods but only in combination with novel and original experimental data (e.g. in cases where new compounds have been designed and tested).Also included in the scope of the journal are articles relating to infectious diseases research on pathogens host-pathogen interactions therapeutics diagnostics vaccines drug-delivery systems and other biomedical technology development pertaining to infectious diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信